Mid-term outcomes after staged transcatheter management of severe native aortic regurgitation and cardiac resynchronisation therapy in a high-risk patient

30 August 2026 (17:12 - 17:24)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Tanya Camuz

Istanbul University-Cerrahpasa Institute of Cardiology, Istanbul (Turkiye)

3 More presentations in this session

Presentation thumbnail

Transcatheter aortic valve implantation under extracorporeal membrane oxygenation in a patient with cardiogenic shock due to a degenerated bioprosthesis

Doctor M. Rodrigues (Rio de Janeiro, BR)

Presentation thumbnail

Navigating the perfect storm: Cardiac Arrest, AMA, and redo TAVI.

Doctor R. Alotaibi (Riyadh, SA)

Presentation thumbnail

Sequential mavacamten therapy and TAVRtavr in an elderly patient with concomitant severe aortic stenosis and obstructive hypertrophic cardiomyopathy

Doctor Y. Wu (Beijing, CN)

Access the full session

Session thumbnail

Transcatheter aortic valve implantation in challenging clinical scenarios

The Event

Event poster

ESC Congress 2026

30 August 2026 17:12 CET

You may be interested in

Congress Presentation

Case 1: concomitant aortic and mitral disease

31 August 2025

Congress Presentation

TAVI for pure aortic regurgitation.

26 August 2022

Congress Presentation

TAVI-in-TAVI as a solution for a complicated TAVI procedure with an aorto-right ventricular fistula due to aortic annulus rupture in an inoperable patient with severe aortic valve regurgitation.

13 December 2024

Congress Presentation

Transcatheter treatment of aortic regurgitation

28 August 2026

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources